Incidence of Pneumocystis jirovecii pneumonia utilizing a polymerase chain reaction-based diagnosis in patients receiving bendamustine.
Mikhaila L RiceJason N BarretoCarrie A ThompsonKristin C ColePritish K ToshAndrew H LimperPublished in: Cancer medicine (2021)
Our incidence of PJP below 3.5%, the conventional threshold for prophylaxis implementation, indicates routine anti-Pneumocystis prophylaxis may not be necessary in this population. Factors indicating a high-risk population for targeted prophylaxis require further investigation.